click below
click below
Normal Size Small Size show me how
USMLE
Pharm 1
Question | Answer |
---|---|
28 year old chemist presents with MPTP exposure. What NT is depleted? | Dopamine |
Woman taking tetracycline exhibits photosensitivity. What are the clinical manifestations? | Rash on sun-exposed regions of body |
Nondiabetic patient presents with hypoglycemia but low levels of C peptide. What is the diagnosis | Surreptitious insulin injection |
African American male who goes to Africa develops hemolytic anemia after taking malaria prophylaxis. What is the enzyme defficiency | Glucose 6 phosphate dehydrogenase |
27 year old female with history of psychiatric illness now has urinary retention due to neuroleptic. What do you treat it with? | Bethanechol |
Farmer presents with dyspnea, salivation, miosis, diarrhea, cramping and blurry vision. What caused this and what is the mechanism | Insecticide poisoning, inhibition of acetylcholinesterase |
Patient with recent kidney transplant is on cyclosporine for immunosuppresion, he requires antifungal agent for candidiasis. What antifungal drug would result in cyclosporine toxicity? | Ketoconazole |
Man on several medications including antidepressants and antihypertensives, has mydriasis and becomes constipated. What is the cause of symptoms? | TCA |
55 year old postmenopausal woman on tamoxifen therapy. What is she at increased risk of acquiring? | Endometrial carcinoma |
Woman on MAO inhibitor has hypertensive crisis after meal. What did she ingest? | Tyramine (wine or cheese) |
After taking clindamycin, patient develops toxic megacolon and diarrhea. What is the mechanism of diarrhea? | Clostridium difficile overgrowth |
Man starts a medication for hyperlipidemia. He then develops rash, pruritus and GI upset. What drug was it? | Niacin |
Patient is on carbamazepine. What routine workup should be done? | LFT's |
23 year old female who is on rifampin for TB prophylaxis and on birth control (estrogen) gets pregnant. Why? | Rifampin augments estrogen metabolism in liver rendering it less effective |
Patient develops cough and must discontinue captopril. WHat is a good replacement drug and why doesnt it have the same side effects? | Losartan - an angiotensin II receptor antagonist, does not increase bradykinin as captopril does |
Relates the amount of drug in the body to plasma concentration | Vd - volume of distribution |
Formule for volume of distribution | Vd = amount of drug in the body/plasma drug concentration |
Vd of plasma protein-bound drugs can be altered by what disease? | Liver and kidney |
Relates the rate of elimination to plasma concentration | CLEARANCE |
Formula for clearance | Cl = rate of elimination of drug/plasma drug concentration |
The time required to change the amount of drug in the body by 1/2 during elimination (or during constant infusion) is called _ | Half life T1/2 |
After 1 half life concentration of drug equals _ % | 50% |
After 2 half lifes concentration of drug equals_ | 75% |
A drug infused at constant rate reaches about _ % of steady state after 4 T1/2 | 94 |
Formula for T1/2 | T1/2 = 0.7 * Vd/CL |
Loading dose formula | Loading dose = Cp * Vd/F, Cp= target plasma concentration, F = bioavailibility |
Formula for maintenance dose | Cp * CL / F, Cp = target plasma concentration, F = bioavailibility |
In patients with impaired renal or hepatic function, the loading dose decreases, increases or remains unchanged? Maintenance dose? | Loading dose remains unchanged, Maintenance dose decreases |
Rate of elimination is constant (constant amount of drug is eliminated per unit time) - what order elimination? What happens to target plasma concentration? | Zero order elimination, Target plasma concentration decreases linearly with time |
Rate of elimination is proportional to drug concentration (constant fraction of drug eliminated per unit time) - what order elimination? What happens to target plasma concentration? | First order elimination, Cp decreases exponentially with time |
Give examples of drugs with zero order elimination | Ethanol, Phenytoin, Aspirin (at high or toxic concentration) |
Phase I metabolism (reduction, oxidation, hydrolysis) yields _ metabolites (often still active) | Slightly polar, water soluble |
What phase of metabolism associated with cytochrome P450 | Phase I |
What phase of metabolism associated with conjugation | Phase I |
Phase II metabolism (acetylation, glucoronidation, sulfation) yields _ metanolites (renally excreted) | Very polar, inactive |
Geriatric patients lose which phase of metabolism first? | Phase I |
Is it safe? Pharmacokinetics? - which phase of clinical testing of the drug | Phase I |
Does it work in patients?- which phase of clinical testing of the drug | Phase II |
Does it work? Double blind - which phase of clinical testing of the drug | Phase III |
What happens in phase IV of clinical testing of the drug | Postmarketing surveillance |
A competitive antagonist shifts agonist curve where? | To the right |
A noncompetitive antagonist (irreversible) shifts agonist curve where? | Downward |
Name antibiotics that block cell wall synthesis by inhibition of peptidoglycan cross linking | Penicillin, Ampicillin, Ticarcillin, Pipercarcillin, Imipenem, Aztreonam, Cephalosporins |
Name antibiotics that block peptidoglycan synthesis | Bacitracin, Vancomycin, Cycloserine |